Literature DB >> 33123723

The Plasma Metabolomic Profile is Differently Associated with Liver Fat, Visceral Adipose Tissue, and Pancreatic Fat.

Lars Lind1, Samira Salihovic2, Ulf Risérus3, Joel Kullberg4,5, Lars Johansson4, Håkan Ahlström4,5, Jan W Eriksson1, Jan Oscarsson6.   

Abstract

CONTEXT: Metabolic differences between ectopic fat depots may provide novel insights to obesity-related diseases.
OBJECTIVE: To investigate the plasma metabolomic profiles in relation to visceral adipose tissue (VAT) volume and liver and pancreas fat percentages.
DESIGN: Cross-sectional.
SETTING: Multicenter at academic research laboratories. PATIENTS: Magnetic resonance imaging (MRI) was used to assess VAT volume, the percentage of fat in the liver and pancreas (proton density fat fraction [PDFF]) at baseline in 310 individuals with a body mass index ≥ 25 kg/m2 and with serum triglycerides ≥ 1.7 mmol/l and/or type 2 diabetes screened for inclusion in the 2 effect of omega-3 carboxylic acid on liver fat content studies. INTERVENTION: None. MAIN OUTCOME MEASURE: Metabolomic profiling with mass spectroscopy enabled the determination of 1063 plasma metabolites.
RESULTS: Thirty metabolites were associated with VAT volume, 31 with liver PDFF, and 2 with pancreas PDFF when adjusting for age, sex, total body fat mass, and fasting glucose. Liver PDFF and VAT shared 4 metabolites, while the 2 metabolites related to pancreas PDFF were unique. The top metabolites associated with liver PDFF were palmitoyl-palmitoleoyl-GPC (16:0/16:1), dihydrosphingomyelin (d18:0/22:0), and betaine. The addition of these metabolites to the Liver Fat Score improved C-statistics significantly (from 0.776 to 0.861, P = 0.0004), regarding discrimination of liver steatosis.
CONCLUSION: Liver PDFF and VAT adipose tissue shared several metabolic associations, while those were not shared with pancreatic PDFF, indicating partly distinct metabolic profiles associated with different ectopic fat depots. The addition of 3 metabolites to the Liver Fat Score improved the prediction of liver steatosis.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society.

Entities:  

Keywords:  MRI; ectopic fat; liver fat; metabolomics; obesity; pancreatic fat

Mesh:

Year:  2021        PMID: 33123723      PMCID: PMC7765636          DOI: 10.1210/clinem/dgaa693

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  37 in total

Review 1.  Waist circumference, visceral obesity, and cardiovascular risk.

Authors:  Paul Poirier; Jean-Pierre Després
Journal:  J Cardiopulm Rehabil       Date:  2003 May-Jun       Impact factor: 2.081

2.  The metabolic syndrome--a new worldwide definition.

Authors:  K George M M Alberti; Paul Zimmet; Jonathan Shaw
Journal:  Lancet       Date:  2005 Sep 24-30       Impact factor: 79.321

3.  Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study.

Authors:  Jan Oscarsson; Kristina Önnerhag; Ulf Risérus; Mattias Sundén; Lars Johansson; Per-Anders Jansson; Linda Moris; Peter M Nilsson; Jan W Eriksson; Lars Lind
Journal:  J Clin Lipidol       Date:  2018-08-10       Impact factor: 4.766

4.  Rediscovery rate estimation for assessing the validation of significant findings in high-throughput studies.

Authors:  Andrea Ganna; Donghwan Lee; Erik Ingelsson; Yudi Pawitan
Journal:  Brief Bioinform       Date:  2014-09-24       Impact factor: 11.622

5.  Branched-chain and aromatic amino acids, insulin resistance and liver specific ectopic fat storage in overweight to obese subjects.

Authors:  S Haufe; H Witt; S Engeli; J Kaminski; W Utz; J C Fuhrmann; D Rein; J Schulz-Menger; F C Luft; M Boschmann; J Jordan
Journal:  Nutr Metab Cardiovasc Dis       Date:  2016-04-07       Impact factor: 4.222

6.  Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.

Authors:  Elisa Fabbrini; Faidon Magkos; B Selma Mohammed; Terri Pietka; Nada A Abumrad; Bruce W Patterson; Adewole Okunade; Samuel Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-24       Impact factor: 11.205

7.  Metabolomic tissue signature in human non-alcoholic fatty liver disease identifies protective candidate metabolites.

Authors:  Witigo von Schönfels; Eleonora Patsenker; René Fahrner; Timo Itzel; Holger Hinrichsen; Mario Brosch; Wiebke Erhart; Auste Gruodyte; Bernd Vollnberg; Klaus Richter; Andreas Landrock; Stefan Schreiber; Stephan Brückner; Guido Beldi; Bence Sipos; Thomas Becker; Christoph Röcken; Andreas Teufel; Felix Stickel; Clemens Schafmayer; Jochen Hampe
Journal:  Liver Int       Date:  2014-03-06       Impact factor: 5.828

8.  A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease.

Authors:  Martina Goffredo; Nicola Santoro; Domenico Tricò; Cosimo Giannini; Ebe D'Adamo; Hongyu Zhao; Gang Peng; Xiaoqing Yu; Tukiet T Lam; Bridget Pierpont; Sonia Caprio; Raimund I Herzog
Journal:  Nutrients       Date:  2017-06-22       Impact factor: 5.717

9.  Body Composition Profiling in the UK Biobank Imaging Study.

Authors:  Jennifer Linge; Magnus Borga; Janne West; Theresa Tuthill; Melissa R Miller; Alexandra Dumitriu; E Louise Thomas; Thobias Romu; Patrik Tunón; Jimmy D Bell; Olof Dahlqvist Leinhard
Journal:  Obesity (Silver Spring)       Date:  2018-05-22       Impact factor: 5.002

10.  Metabolomics Profiling of Visceral Adipose Tissue: Results From MESA and the NEO Study.

Authors:  Ian J Neeland; Sebastiaan C Boone; Dennis O Mook-Kanamori; Colby Ayers; Roelof A J Smit; Ioanna Tzoulaki; Ibrahim Karaman; Claire Boulange; Dhananjay Vaidya; Naresh Punjabi; Matthew Allison; David M Herrington; J Wouter Jukema; Frits R Rosendaal; Hildo J Lamb; Ko Willems van Dijk; Philip Greenland; Renée de Mutsert
Journal:  J Am Heart Assoc       Date:  2019-05-07       Impact factor: 5.501

View more
  2 in total

1.  Multi-omics analysis to decipher the molecular link between chronic exposure to pollution and human skin dysfunction.

Authors:  Namita Misra; Cécile Clavaud; Florent Guinot; Nasrine Bourokba; Stephanie Nouveau; Sakina Mezzache; Paul Palazzi; Brice M R Appenzeller; Arthur Tenenhaus; Marcus H Y Leung; Patrick K H Lee; Philippe Bastien; Luc Aguilar; Nükhet Cavusoglu
Journal:  Sci Rep       Date:  2021-09-15       Impact factor: 4.379

Review 2.  Fatty Pancreas-Centered Metabolic Basis of Pancreatic Adenocarcinoma: From Obesity, Diabetes and Pancreatitis to Oncogenesis.

Authors:  Ming-Ling Chang
Journal:  Biomedicines       Date:  2022-03-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.